Search:
 
BIOTECHNOLOGY RESEARCH

 

USV has evolved from a reliable producer of Dosage Forms and APIs to a process-driven and research-focused company with an emerging global base.

The focus on research in protein and peptide production by recombinant and chemical synthesis has yielded excellent results, with most of the molecules being ready for pilot level scale-up.

USV has also entered into a license agreement with Biotech Consortium India Ltd. (BCIL) to scale-up, manufacture and market a novel conjugate typhoid vaccine developed by a team of scientists at the All India Institute of Medical Sciences (AIIMS), New Delhi. The project is supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. This project would give USV a foray into the new niche area of vaccines.

Achievements
  • Robust and scalable processes for production of Bio-similar recombinant proteins and peptides
  • Successful development of ART media
  • Synthesis of eptifibatide which has been made available in the Indian market.
Capabilities
The P2 BRL includes
  • Molecular Biology (genetic engineering)
  • Tissue Culture
  • Microbiology
  • Fermentation
  • Peptide & Nucleotide
  • Protein Purification, and
  • Analytical facilities to support the above
 
 
Molecular Biology
Microbiology
Fermentation
Peptide & Nucleotide
Protein Purification
Tissue Culture
Custom Peptide Synthesis